Short-term effect of IPED regimen in treatment of refractory Non-Hodgkun's lymphoma
Jianning Wei
Abstract
Jianning Wei
Abstract
Objective To observe the effect and toxicity of IPED regimen in treatment of refractory Non-Hodgkin's Lymphoma.Methods All 21 patients were treated over two cycles with IPED regimen. The IPED regimen was repeated every 28 days. The therapeutic effect was observed after treatment.Results 5 patients achieved complete remission(CR) ,10 partial remission(PR) 3 stable disease(SD),3 progression disease(PD). The overall response rate was 71.4%.The main side effects were myelosuppression and gastrointestinal reaction.Conclusion The IPED regimen is effective in the treatment of refractory Non-Hodgkin's lymphoma and it's toxicity is tolerable.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect and toxicity of IPED regimen in treatment of refractory Non-Hodgkin's Lymphoma.Methods All 21 patients were treated over two cycles with IPED regimen. The IPED regimen was repeated every 28 days. The therapeutic effect was observed after treatment.Results 5 patients achieved complete remission(CR) ,10 partial remission(PR) 3 stable disease(SD),3 progression disease(PD). The overall response rate was 71.4%.The main side effects were myelosuppression and gastrointestinal reaction.Conclusion The IPED regimen is effective in the treatment of refractory Non-Hodgkin's lymphoma and it's toxicity is tolerable.
Key concepts: Regimen, Refractory (planetary science), Medicine, Lymphoma, Toxicity, Internal medicine, Gastroenterology, Complete remission